Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Descrição
Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke – topic of research paper in Clinical medicine. Download scholarly article PDF and
Tissue Plasminogen Activator Market is estimated to be valued at US$ 2,455.4 million in 2022 and is expected to exhibit a CAGR of 5.2% over the forecast period (2020-2027).
Reconstituting Guidelines for Activase® (alteplase)
Alteplase - Wikipedia
Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review, International Journal of Emergency Medicine
Hyperacute Management of Ischemic Strokes: JACC Focus Seminar
Alteplase (Chapter 3) - Essential Neuropharmacology
IJMS, Free Full-Text
Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
